Data / New clinical trials / Psychotic Disorders

Psychotic Disorders trials: 168 new since Nov 2024

Name: New Psychotic Disorders clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Psychotic Disorders clinical trials: 168 rows for $8.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 9 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/psychotic-disorders, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

168 clinical studies in Psychotic Disorders were first posted on ClinicalTrials.gov from November 13, 2024 to November 6, 2026; 10 have an industry sponsor and 132 are recruiting or about to. The newest, NCT07921966, was posted on November 6, 2026: Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult... (Neurelis, Inc.).

The request: Every new Psychotic Disorders clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

168New trials
10Industry sponsored
132Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 168, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07921966	Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants	Neurelis, Inc.	Phase 1	Not yet recruiting	Healthy Adult Participants	24		clinicaltrials.gov
October 29, 2026	NCT07902518	Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations	Ciusss de L'Est de l'Île de Montréal	Not applicable	Recruiting	Auditory Verbal Hallucinations, Schizophrenia, Schizoaffective Disorder, Psychotic Disorders	12	Canada	clinicaltrials.gov
October 28, 2026	NCT07900893	Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3	Washington University School of Medicine	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder), Healthy Adult	10,000	United States	clinicaltrials.gov
October 27, 2026	NCT07898852	Integrated Psychoeducation Program for Internalized Stigma in Schizophrenia	Dokuz Eylul University	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder, Internalized Stigma, Social Stigma	50	Turkey (Türkiye)	clinicaltrials.gov
October 27, 2026	NCT07898631	Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide	Butler Hospital	Not applicable	Not yet recruiting	Suicide, Mental Health Stigma	35	United States	clinicaltrials.gov
October 22, 2026	NCT07888894	Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders	Uppsala University	Not applicable	Not yet recruiting	Psychoses, Metabolic Syndrome	60		clinicaltrials.gov
October 19, 2026	NCT07881016	French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism...	Fondation FondaMental	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive...	3,000	France	clinicaltrials.gov
October 16, 2026	NCT07879131	A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness	Alexandria University	Not applicable	Not yet recruiting	Severe Mental Illness, Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Major Depressive Disorder	60	Bahrain	clinicaltrials.gov
October 16, 2026	NCT07879118	Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness	Biruni University	Not applicable	Not yet recruiting	Schizophenia Disorder, Severe Mental Illness, Bipolar Disorder, Nonorganic Psychosis, Schizo-affective Disorder	50	Turkey (Türkiye)	clinicaltrials.gov
October 15, 2026	NCT07876089	Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of...	University Hospital, Aachen	Observational	Active not recruiting	Schizophrenia / Schizoaffective Disorder	3,692	Germany	clinicaltrials.gov
October 15, 2026	NCT07875790	Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2	Washington University School of Medicine	Not applicable	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder, Healthy Adult	325	United States	clinicaltrials.gov
October 9, 2026	NCT07867964	Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders	Boston Children's Hospital	Not applicable	Not yet recruiting	Schizophrenia; Psychosis	20	United States	clinicaltrials.gov
October 2, 2026	NCT07853807	Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1	Washington University School of Medicine	Not applicable	Recruiting	SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder, Healthy Adult Participants	325	United States	clinicaltrials.gov
October 1, 2026	NCT07853079	Motivational Intervention for Patients With Schizophrenia	University of Geneva, Switzerland	Not applicable	Not yet recruiting	Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder	88		clinicaltrials.gov
September 23, 2026	NCT07836348	A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward	Jerusalem Mental Health Center	Not applicable	Recruiting	Psychotic Disorders	200	Israel	clinicaltrials.gov
September 22, 2026	NCT07834203	State Representation in Early Psychosis 2	University of Minnesota	Observational	Recruiting	Early Psychosis, Psychosis, Schizophrenia, Bipolar Disorder With Psychosis, Schizoaffective Disorder	500	United States	clinicaltrials.gov
September 15, 2026	NCT07820553	Building a Computational Model of Auditory Hallucinations	King's College London	Observational	Not yet recruiting	Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA...	146		clinicaltrials.gov
September 14, 2026	NCT07818668	tACS for Self-Other Boundary in Schizophrenia	Chunyan Zhu	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder	100	China	clinicaltrials.gov
September 14, 2026	NCT07818603	Screening and Monitoring of Mental Health in Educational Settings: Programme for Detection, Psychoeducation and Self-help	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Not applicable	Completed	Anxiety, Depression Disorder, Bullying, Addiction, Suicide, Self Harm, Psychosis, Eating Disorders	436	Spain	clinicaltrials.gov
September 11, 2026	NCT07815587	Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers	St. Olavs Hospital	Observational	Not yet recruiting	Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder), Intramuscular Injection	60		clinicaltrials.gov
September 10, 2026	NCT07811466	Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis	Centre hospitalier de l'Université de Montréal (CHUM)	Not applicable	Not yet recruiting	First Episode Psychosis (FEP), Psychosis, Schizophreni-form Disorder, Dependence Addictive	550		clinicaltrials.gov
September 8, 2026	NCT07806877	Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia	Central South University	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder, TMS, Cognitive, PET / MR	60		clinicaltrials.gov
August 27, 2026	NCT07791212	Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases	King's College London	Observational	Not yet recruiting	Neuropsychiatric Symptom	300	United Kingdom	clinicaltrials.gov
August 26, 2026	NCT07788755	NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia	University of Minnesota	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment	168	United States	clinicaltrials.gov
August 26, 2026	NCT07786714	Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis	Douglas Mental Health University Institute	Not applicable	Recruiting	Clinical High Risk for Psychosis (CHR), Psychotic Disorders, Prodromal Symptoms	40	Canada	clinicaltrials.gov
August 20, 2026	NCT07777315	Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode Psychosis	Centre for Addiction and Mental Health	Not applicable	Not yet recruiting	Psychosis	32		clinicaltrials.gov
August 12, 2026	NCT07759895	Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia	Amit Lotan	Phase 2	Recruiting	Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms	80	Israel	clinicaltrials.gov
August 10, 2026	NCT07756567	Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis	University of California, San Diego	Not applicable	Recruiting	Clinical High Risk for Psychosis (CHR), Suicidal Ideation, Psychosis, Suicidal Behavior	108	United States	clinicaltrials.gov
August 5, 2026	NCT07747181	The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis	The Hong Kong Polytechnic University	Not applicable	Recruiting	Cognitive Functioning, Psychosis	135	Hong Kong	clinicaltrials.gov
July 21, 2026	NCT07716969	TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis	Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital	Observational	Recruiting	Psychosis, Schizo Affective Disorder, SCHIZOPHRENIA 1 (Disorder)	250	Denmark	clinicaltrials.gov
July 20, 2026	NCT07715253	Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia	New York State Psychiatric Institute	Phase 1	Not yet recruiting	Schizoaffective Disorder, Schizophreniform Disorder, Schizophrenia	100		clinicaltrials.gov
July 20, 2026	NCT07713849	Transition Care for FEP	University of Chicago	Observational	Recruiting	Schizoaffective Disorders, Bipolar Disorder With Psychotic Features, Schizophrenia Disorders, Major Depressive Disorder...	75	United States	clinicaltrials.gov
July 16, 2026	NCT07708402	Healing Stigma Through Stories	National Yang Ming Chiao Tung University	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	24		clinicaltrials.gov
July 14, 2026	NCT07703670	MicroRNAs as Biomarkers in First Episode Schizophrenia	Northwell Health	Not applicable	Recruiting	Schizophrenia Disorder, Schizophreniform Disorder, Schizoaffective Disorder, Psychosis Not Otherwise Specified (NOS)	160	United States	clinicaltrials.gov
July 10, 2026	NCT07696000	The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic...	DINA KEUMALA SARI	Not applicable	Recruiting	Schizophrenia / Schizoaffective Disorder	100	Indonesia	clinicaltrials.gov
June 30, 2026	NCT07674914	A Cognitive Mobile Intervention for Motivation in Psychotic Disorders	University of Alabama at Birmingham	Phase 1/2	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	45	United States	clinicaltrials.gov
June 29, 2026	NCT07673718	α-N-acetylgalactosaminidase in Schizoaffective Disorder	Elazığ Mental Health and Diseases Hospital	Observational	Completed	Schizoaffective Disorder	93	Turkey (Türkiye)	clinicaltrials.gov
June 26, 2026	NCT07671261	SEEG-Guided DBS for Schizophrenia	Ruijin Hospital	Not applicable	Recruiting	Schizophrenia Disorders, Schizo Affective Disorder	46	China	clinicaltrials.gov
June 22, 2026	NCT07660874	Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.	Queen's University, Belfast	Not applicable	Active not recruiting	Mental Health Promotion	120	United Kingdom	clinicaltrials.gov
June 22, 2026	NCT07658391	Optimizing CBSST With Executive Function Training for Schizophrenia (R33)	University of California, San Diego	Not applicable	Not yet recruiting	Schizophrenia, Schizoaffective Disorder	106	United States	clinicaltrials.gov
June 12, 2026	NCT07645443	FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis	Stephanie Mehl	Not applicable	Recruiting	Delusional Disorder, Brief Psychotic Disorder, Schizophreniform Disorder, Schizophrenia / Schizoaffective Disorder...	252	Germany	clinicaltrials.gov
June 3, 2026	NCT07623928	Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis	King's College London	Not applicable	Not yet recruiting	Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophrenia and Related Disorders	15	United Kingdom	clinicaltrials.gov
June 2, 2026	NCT07621549	Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia	Far Eastern Memorial Hospital	Not applicable	Recruiting	Schizo Affective Disorder	80	Taiwan	clinicaltrials.gov
May 29, 2026	NCT07615075	Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With...	University of Maryland, Baltimore	Phase 4	Not yet recruiting	Schizophrenia, Schizo Affective Disorder, Healthy	40	United States	clinicaltrials.gov
May 27, 2026	NCT07609953	Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia	Hasanuddin University	Not applicable	Completed	Schizophrenia	42	Indonesia	clinicaltrials.gov
May 26, 2026	NCT07606014	No Guts No Glory Probiotics	University Medical Center Groningen	Phase 2/3	Recruiting	Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine	112	Netherlands	clinicaltrials.gov
May 22, 2026	NCT07602712	Using Illusions to Boost Social Cognition	Hôpital le Vinatier	Not applicable	Not yet recruiting	Schizophrenia Spectrum Disorders, Social Cognition	60	France	clinicaltrials.gov
May 18, 2026	NCT07593456	NST-SPARK Open-Label Phase 1 STTR (IGNITE)	North Shore Therapeutics, Inc.	Not applicable	Not yet recruiting	Schizophrenia / Schizoaffective Disorder	30	United States	clinicaltrials.gov
May 6, 2026	NCT07569471	REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in Psychosis	University of Toronto	Not applicable	Recruiting	Schizophrenia Spectrum & Other Psychotic Disorders	38	Canada	clinicaltrials.gov
April 29, 2026	NCT07555275	Testing a Peer-Support Group for Veterans Who Hear Voices	VA Office of Research and Development	Not applicable	Not yet recruiting	Psychotic Disorders, Hallucinations, Auditory, Social Isolation	160	United States	clinicaltrials.gov
April 13, 2026	NCT07523256	Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia	Rinvil Renaldi	Not applicable	Completed	Schizophrenia, Psychotic Disorders	44	Indonesia	clinicaltrials.gov
April 3, 2026	NCT07509125	Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders	Universitaire Ziekenhuizen KU Leuven	Not applicable	Recruiting	Alzheimer Dementia (AD), ALS - Amyotrophic Lateral Sclerosis, Parkinson s Disease, REM Sleep Behavior Disorder (iRBD)...	300	Belgium	clinicaltrials.gov
March 31, 2026	NCT07503093	Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis	Mclean Hospital	Not applicable	Not yet recruiting	Psychosis, Anxiety, Depression, Rumination	10	United States	clinicaltrials.gov
March 30, 2026	NCT07499934	Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study	Centre Psychothérapique de Nancy	Not applicable	Recruiting	Clinical High Risk for Psychosis (CHR)	20	France	clinicaltrials.gov
March 23, 2026	NCT07488156	Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder	Louisiana State University Health Sciences Center in New Orleans	Not applicable	Not yet recruiting	Schizophrenia Disorder, Schizoaffective Disorder, Psychosis	34	United States	clinicaltrials.gov
March 19, 2026	NCT07483294	Cerebellum-based Imaging Neural Markers for Antipsychotic Response	Northwell Health	Phase 4	Recruiting	Psychosis; Acute	120	United States	clinicaltrials.gov
March 13, 2026	NCT07470437	The Mouth Matters in Mental Health Trial -2	Lancashire and South Cumbria NHS Foundation Trust	Not applicable	Recruiting	Mental Health, Oral Health Care, Psychosis	480	United Kingdom	clinicaltrials.gov
March 13, 2026	NCT07469384	Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways	Nathan Kline Institute for Psychiatric Research	Not applicable	Recruiting	SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder	120	United States	clinicaltrials.gov
March 10, 2026	NCT07460453	Racial Disparities in the Expression of Paranoia	Indiana University	Not applicable	Recruiting	Paranoia, Psychotic Disorders	480	United States	clinicaltrials.gov
March 10, 2026	NCT07459660	An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis	MapLight Therapeutics	Phase 2	Enrolling by invitation	Psychosis Associated With Alzheimer's Disease	210	Bulgaria, France, United States	clinicaltrials.gov
March 10, 2026	NCT07459647	A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia	MapLight Therapeutics	Phase 2	Recruiting	Schizophrenia	500	United States	clinicaltrials.gov
March 6, 2026	NCT07455929	Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders	Charite University, Berlin, Germany	Not applicable	Recruiting	Psychotic Disorders, Schizophrenia Spectrum Disorders	60	Germany	clinicaltrials.gov
March 4, 2026	NCT07450027	LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis	Elazığ Mental Health and Diseases Hospital	Observational	Completed	Methamphetamine Use Disorder, Methamphetamine-induced Psychosis	111	Turkey (Türkiye)	clinicaltrials.gov
March 4, 2026	NCT07447960	LRFN5 and OLFM4 in Schizoaffective Disorder	Elazığ Mental Health and Diseases Hospital	Observational	Completed	Schizoaffective Disorder	110	Turkey (Türkiye)	clinicaltrials.gov
March 3, 2026	NCT07446569	Perception and Integration of Sensory Information in the Early Stages of Psychosis	Centre Psychothérapique de Nancy	Not applicable	Not yet recruiting	Early Psychosis, Schizophrenia Prodromal	294	France	clinicaltrials.gov
March 3, 2026	NCT07445620	Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on...	All India Institute of Medical Sciences, Bhubaneswar	Not applicable	Not yet recruiting	Psychosis, Schizophrenia Disorder	90	India	clinicaltrials.gov
February 27, 2026	NCT07436481	The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of...	Natalia Dewi Wardani, MD	Not applicable	Completed	Psychotic Disorder	80	Indonesia	clinicaltrials.gov
February 27, 2026	NCT07434973	Stratification and Treatment in Early Psychosis Study - PROMOTE	University of Oxford	Phase 3	Not yet recruiting	Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis	586	Austria, Canada, Finland, Germany, Greece, Italy, Netherlands, Spain...	clinicaltrials.gov
February 25, 2026	NCT07434401	α-N-acetylgalactosaminidase in Methamphetamine Psychosis	Elazığ Mental Health and Diseases Hospital	Observational	Completed	Methamphetamine Use Disorder, Methamphetamine-induced Psychosis	93	Turkey (Türkiye)	clinicaltrials.gov
February 23, 2026	NCT07427485	Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study	Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco	Not applicable	Completed	SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder	40	Italy	clinicaltrials.gov
February 19, 2026	NCT07419321	Social Isolation and Aging in Schizophrenia	Icahn School of Medicine at Mount Sinai	Observational	Recruiting	Schizophrenia and Related Disorders	650	Netherlands, Spain, United Kingdom, United States	clinicaltrials.gov
February 18, 2026	NCT07417904	BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis	Howard University	Not applicable	Recruiting	Violence Risk, Early Psychosis	30	United States	clinicaltrials.gov
February 13, 2026	NCT07408934	A Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme)	The Royal Ottawa Mental Health Centre	Not applicable	Enrolling by invitation	Schizophrenia and Schizoaffective Disorder	50	Canada	clinicaltrials.gov
February 9, 2026	NCT07398365	Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients	University of Edinburgh	Observational	Recruiting	Bipolar Affective Disorder, Schizophrenia Disorders, Depression Disorders, Personality Disorders	100	United Kingdom	clinicaltrials.gov
February 9, 2026	NCT07397975	Speech-based Assessment of Relapse Risk in People With Psychosis	Philipp Homan	Observational	Recruiting	Psychotic Disorder	360	Czechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye)	clinicaltrials.gov
February 9, 2026	NCT07395206	Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders	Charite University, Berlin, Germany	Not applicable	Recruiting	Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia...	60	Germany	clinicaltrials.gov
February 4, 2026	NCT07386483	Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome	University College Dublin	Not applicable	Not yet recruiting	Psychosis	40	Ireland	clinicaltrials.gov
January 29, 2026	NCT07374588	Impact of Medication Education on Adherence and Side Effects	Cumhuriyet University	Not applicable	Completed	Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Psychotic Features, Major Depressive Disorder With...	64	Turkey (Türkiye)	clinicaltrials.gov
January 23, 2026	NCT07364825	Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care	Brigham and Women's Hospital	Not applicable	Completed	Psychosis, Anxiety, Depression, Behavioral and Psychiatric Symptoms of Dementia	41	United States	clinicaltrials.gov
January 22, 2026	NCT07360665	Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable...	University of Trás-os-Montes and Alto Douro	Not applicable	Recruiting	Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD), Severe Mental Illness	44	Portugal	clinicaltrials.gov
January 22, 2026	NCT07359157	Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital	Massachusetts General Hospital	Not applicable	Recruiting	Serious Mental Illness, Psychotic Disorder, Depression, Bipolar	40	United States	clinicaltrials.gov
January 15, 2026	NCT07343193	Deprescribing Antipsychotics: a Multiple Case Study	University Hospital, Strasbourg, France	Observational	Recruiting	Psychotic Disorder	30	France	clinicaltrials.gov
January 15, 2026	NCT07342764	Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial	Sultan Qaboos University	Phase 4	Not yet recruiting	Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain	110	Oman	clinicaltrials.gov
January 9, 2026	NCT07330843	Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery...	Centre Hospitalier Universitaire de Nīmes	Observational	Not yet recruiting	Psychosis, Mental Disorder	96	France	clinicaltrials.gov
January 8, 2026	NCT07326124	Stratification and Treatment in Early Psychosis Study -ASSIST	University of Oxford	Phase 3	Not yet recruiting	Treatment Resistant Psychosis, Psychosis	250	Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom	clinicaltrials.gov
December 11, 2025	NCT07276321	Preliminary Efficacy of an mHealth Intervention in West Africa	University of Washington	Not applicable	Recruiting	Psychosis	50	Ghana	clinicaltrials.gov
December 4, 2025	NCT07263022	Cognitive Strategies in Early Psychosis 2	University of Minnesota	Phase 3	Recruiting	Psychosis, Schizophrenia Disorder, Schizoaffective Disorder, Major Depressive Disorder With Psychotic Features, Bipolar...	24	United States	clinicaltrials.gov
November 26, 2025	NCT07252206	A Case Series of Culturally-adapted CBTp for Black People in the UK	University of Manchester	Not applicable	Recruiting	Psychosis, Schizophrenia Spectrum Disorders	6	United Kingdom	clinicaltrials.gov
November 24, 2025	NCT07245212	Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients...	King's College London	Not applicable	Not yet recruiting	Psychosis, Cannabis Use Disorder, First Episode Psychosis (FEP)	80	United Kingdom	clinicaltrials.gov
November 19, 2025	NCT07237529	What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis?	University of Nottingham	Not applicable	Not yet recruiting	Psychosis, Schizophrenia and Other Psychotic Disorders	1		clinicaltrials.gov
November 17, 2025	NCT07231497	Cognitive Strategies in Early Psychosis 1	University of Minnesota	Phase 3	Recruiting	Cognition, Healthy Participants	103	United States	clinicaltrials.gov
October 9, 2025	NCT07213492	Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder	McMaster University	Not applicable	Recruiting	Bipolar Disorder (BD), Psychosis	10	Canada	clinicaltrials.gov
October 9, 2025	NCT07213466	Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder	Mayo Clinic	Phase 4	Recruiting	Bipolar I Disorder, Bipolar II Disorder, Schizo Affective Disorder, Obesity, Weight Loss, GLP - 1	100	United States	clinicaltrials.gov
September 29, 2025	NCT07196462	Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia	Vanderbilt University Medical Center	Not applicable	Recruiting	Cannabis Use, SCHIZOPHRENIA, Psychosis, rTMS	100	United States	clinicaltrials.gov
September 29, 2025	NCT07196423	Early Psychosis: Investigating Cognition	University of Nottingham	Not applicable	Recruiting	First Episode Psychosis (FEP), Psychosis	106	United Kingdom	clinicaltrials.gov
September 22, 2025	NCT07184710	This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases...	Sohag University	Observational	Not yet recruiting	Comparing Clinical Profile and Prognosis of Schizophrenia Versus Methamphetamine Induced Psychosis, SCHIZOPHRENIA...	200		clinicaltrials.gov
September 10, 2025	NCT07165821	Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients	Suranaree University of Technology	Not applicable	Completed	Schizophrenia; Psychosis, Remission, Non-Adherence, Medication	40	Thailand	clinicaltrials.gov
September 5, 2025	NCT07157293	Online Intervention To Improve Motivation	University of Alabama at Birmingham	Not applicable	Not yet recruiting	Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder), Psychosis	60	United States	clinicaltrials.gov
August 22, 2025	NCT07137572	Arts-based Social Prescribing for Mental Health	KAVADIA ELENI	Not applicable	Completed	Mental Health Issue, Anxiety Disorders, Affective Disorders, Affective Disorders, Psychotic, Psychotic Disorder...	541	Greece	clinicaltrials.gov
August 19, 2025	NCT07130500	Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization	Stanford University	Not applicable	Enrolling by invitation	Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD), Substance Use Disorder (SUD)	1,000	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
King's College London	7	September 15, 2026
Douglas Mental Health University Institute	6	August 26, 2026
University of Minnesota	4	September 22, 2026
University of California, San Diego	4	August 10, 2026
Elazığ Mental Health and Diseases Hospital	4	June 29, 2026
MapLight Therapeutics	4	March 10, 2026
Washington University School of Medicine	3	October 28, 2026
VA Office of Research and Development	3	April 29, 2026
Centre Psychothérapique de Nancy	3	March 30, 2026
Charite University, Berlin, Germany	3	March 6, 2026
University of Oxford	3	February 27, 2026
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital	2	July 21, 2026
New York State Psychiatric Institute	2	July 20, 2026
Northwell Health	2	July 14, 2026
University of Alabama at Birmingham	2	June 30, 2026
Massachusetts General Hospital	2	January 22, 2026
University of Nottingham	2	November 19, 2025
Vanderbilt University Medical Center	2	September 29, 2025
Stanford University	2	August 19, 2025
Nova Scotia Health Authority	2	July 9, 2025

By phase

Phase	New trials	Latest
Not applicable	106	October 29, 2026
Observational	36	October 15, 2026
Phase 3	8	February 27, 2026
Phase 4	7	May 29, 2026
Phase 2	6	August 12, 2026
Phase 1	3	November 6, 2026
Phase 1/2	1	June 30, 2026
Phase 2/3	1	May 26, 2026

By country

Country	New trials	Latest
United States	53	October 28, 2026
Canada	18	October 29, 2026
United Kingdom	16	August 27, 2026
France	13	October 19, 2026
Germany	10	October 15, 2026
Turkey (Türkiye)	9	October 27, 2026
Italy	9	February 27, 2026
Spain	8	September 14, 2026
Netherlands	7	May 26, 2026
Greece	6	February 27, 2026
Switzerland	6	February 27, 2026
Israel	5	September 23, 2026
China	5	September 14, 2026
Indonesia	4	July 10, 2026
Denmark	3	July 21, 2026
Taiwan	3	June 2, 2026
Austria	3	February 27, 2026
Czechia	3	February 9, 2026
Ireland	3	February 9, 2026
Belgium	2	April 3, 2026
Bulgaria	2	March 10, 2026
Norway	2	February 9, 2026
Portugal	2	January 22, 2026
Hungary	2	July 25, 2025
Pakistan	2	June 5, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.